Medication info
Talpurin Tablet (Talniflumate)

Talpurin Tablet (Talniflumate)

Prescription medicationTabletOral
Ingredient · strength
Talniflumate›370mg / 1 tablet
Manufacturer / importer
Withus Pharmaceutical Co., Ltd.
Appearance
Orange round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200202362 · Notified 2002.03.19 · Insurance code 660701780

Summary

Main use
Relief of arthritis (such as osteoarthritis)
Who takes it
Adults
Adult dose
Administer 370 mg of talniflumate orally 3 times daily. For severe cases, administer 740 mg per dose. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
Withus Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of arthritis (such as osteoarthritis)

  • Rheumatoid arthritis
  • osteoarthritis
  • degenerative arthritis
View approved original text

Rheumatoid arthritis and osteoarthritis (degenerative arthritis) are representative joint diseases. Rheumatoid arthritis is a chronic disease characterized by inflammation of the joints due to immune system dysfunction, while osteoarthritis is a degenerative disease resulting from the wear and tear of joint cartilage. This medication is used for these major types of arthritis.

How to take

Adult dose

Administer 370 mg of talniflumate orally 3 times daily. For severe cases, administer 740 mg per dose. Adjust the dose as appropriate according to age and symptoms.

Precautions

This medication may cause gastric bleeding in individuals who regularly consume three or more alcoholic drinks per day, and it is crucial to consult a doctor or pharmacist before use. This medication may affect the cardiovascular system and increase the risk of serious cardiovascular diseases such as myocardial infarction or stroke, so caution is necessary for patients with cardiovascular diseases or risk factors. This medication can cause serious gastrointestinal side effects such as gastrointestinal bleeding, ulcers, and perforation; therefore, elderly patients or those with a history of gastrointestinal disease should be particularly careful. Patients with peptic ulcers, allergies to the ingredients of this medication, pregnant women or those who may become pregnant, and patients with severe liver, kidney, or heart diseases should not take this medication. Patients with mild to moderate liver, kidney, or heart dysfunction, elderly patients, and those allergic to specific pigment components should use this medication with caution. This medication may cause gastrointestinal symptoms such as nausea, vomiting, diarrhea, and rarely cardiovascular symptoms, skin rashes, severe skin reactions, or kidney function decline; thus, any unusual symptoms should be immediately reported to healthcare personnel. This medication should be used at the lowest effective dose and for the shortest duration possible, and regular blood tests and liver and kidney function tests are necessary during long-term use. This medication should not be taken with other anti-inflammatory analgesics, and it may interact with specific medications; therefore, inform your doctor or pharmacist of any other medications you are taking. Pregnant women, especially those in late pregnancy, or breastfeeding women should not use this medication, and it should not be administered to children under 12 years of age. Elderly patients should be especially cautious about potential side effects when taking this medication and should store it in a safe place out of the reach of children.

Side effects

  • Nausea
  • vomiting
  • photosensitivity
  • asthma attack
  • generalized weakness due to hypotension
  • hypersensitivity shock
  • diarrhea
  • abdominal distension
  • constipation
  • dyspepsia
Show 32 more
  • ulcerative stomatitis
  • abdominal pain
  • hematemesis
  • colitis
  • exacerbation of Crohn's disease
  • gastrointestinal bleeding
  • peptic ulcer
  • perforation
  • hypertension
  • tachycardia
  • chest pain
  • arrhythmia
  • palpitations
  • hypotension
  • congestive heart failure
  • edema
  • hypertension
  • heart failure
  • vesicular reaction
  • Stevens-Johnson syndrome
  • Reiter's syndrome
  • rash
  • urticaria
  • pruritus
  • purpura
  • dizziness
  • acute renal failure
  • interstitial nephritis
  • nephrotic syndrome
  • fluoride toxicity
  • abnormal liver function tests
  • thrombocytopenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air exposure, ideally at room temperature between 1°C and 30°C. Proper storage conditions help maintain the effectiveness of the medication over time.

Appearance and packaging

Appearance

Orange round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.